Close menu




 

André Will-Laudien

  • Energy
  • Ressources
  • Technology

Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets. In the historic dot.com year 2000, he trained as a CEFA analyst in Frankfurt and has since then accompanied over 20 IPOs in Germany.

Until 2018, he held various positions at banks as an asset manager, capital market and macro expert as well as fundamental equity analyst. He is passionate about the energy, commodity and technology markets as well as the tactical and strategic asset allocation of liquid investment products. As an expert speaker at investment committee meetings of funds as well as at customer events, he can still describe the course of the 1987 crash, one of the major buying opportunities of the last 33 years on the stock market.

Today, he knows that the profit in shares is not necessarily the result of buying cheaply, but above all of avoiding mistakes and recognizing in good time when markets are ready to let air out. After all, in addition to basic fundamental analysis, investing in stocks is above all a phenomenon of global liquidity and this must be monitored regularly.


Commented by André Will-Laudien

Commented by André Will-Laudien on August 6th, 2025 | 07:30 CEST

DAX celebrates, Palantir sets the pace! Strong rebound for Almonty, Mutares, and Steyr!

  • Mining
  • Tungsten
  • Defense
  • Automotive
  • Software

It is earnings season, with over 200 quarterly reports coming in from around the world every day. Investors are focusing heavily on revenue growth at defense companies. This is because they should benefit significantly from the lavish contracts awarded by NATO and other defense-oriented countries. The environment remains unstable, and geopolitically, anything is possible. However, defense stocks have often risen so far that the hoped-for earnings figures for 2027 to 2030 are already reflected in today's prices. But the rally continues! After a sharp correction at Almonty Industries, many are delighted to have a cheaper entry point into the tungsten expert, as strategic metals are high on the shopping list, especially in the defense sector. The problem is that they are scarce and difficult to obtain. Where are the opportunities for investors?

Read

Commented by André Will-Laudien on August 6th, 2025 | 07:20 CEST

Inevitable: High-tech and AI require strategic metals! Share price gains at Siemens Energy, Nordex, and Power Metallic

  • Mining
  • Lithium
  • Copper
  • StrategicMetals
  • renewableenergies
  • Batteries

The availability of strategic metals is geopolitically risky because China controls the global market for most of these raw materials, from extraction to processing. The EU and the US are increasingly facing the problem that geopolitical conflicts and export restrictions can quickly lead to supply bottlenecks and price spikes. The COVID-19 pandemic and the war in Ukraine have painfully exposed the dependence of Western industrialized countries. In addition, demand for strategic metals is growing rapidly. Experts expect demand for lithium, for example, to increase twentyfold by 2050. Anyone who wants to secure long-term innovation and prosperity, therefore, needs independent sources of supply and new players in the raw materials market. We are looking around!

Read

Commented by André Will-Laudien on August 5th, 2025 | 07:25 CEST

Correction over? The next doublers could be Puma and Veganz, while Nike and Adidas remain under pressure!

  • Vegan
  • Food
  • Retail
  • ecommerce
  • Sportswear

After the DAX fell 700 points in just 24 hours, investors are wondering whether last week's correction is already over. Over 60% of all S&P 500 companies have already reported their mid-year results, but the figures have not been enough to push the index higher across the board. This gives pause for thought and suggests that the correction is set to continue. While things are going well for plant-based nutrition specialist Veganz, sports consumers are coming under increasing pressure. US tariffs are becoming a problem for Adidas in the highly competitive sneaker market, and things are also looking tight for the popular Puma models. Nike could benefit from this, but its shares are costly. Who will be able to perform better in the slow summer months?

Read

Commented by André Will-Laudien on August 5th, 2025 | 07:10 CEST

Palantir, Rheinmetall, RENK, and Dryden Gold: Winners in the crossfire of trade war and NATO agenda

  • Mining
  • Gold
  • Commodities
  • Defense
  • Software
  • Technology
  • NATO

Tariffs, defense, and infrastructure! No wonder there is a considerable gap of around EUR 172 billion in the German federal budget between 2027 and 2029. Although the federal government is attempting to counter this with spending cuts, tax increases will ultimately be necessary, as migration and climate costs are also taking their toll. Those in government who now have to juggle everything at once are in for a rough ride! Government revenues are expected to continue to decline due to the sluggish economy and high inflation, meaning the government will face higher refinancing costs due to rising interest rates. For investors, this means that the price of gold is likely to increase further, making selective investments in precious metals a sensible move. We will briefly analyze whether there is still room for growth in the well-performing defense and military stocks.

Read

Commented by André Will-Laudien on August 4th, 2025 | 07:10 CEST

Correction or Crash? Gold and these stocks are holding their ground – Heidelberger Druck, Desert Gold, and DroneShield

  • Mining
  • Gold
  • Drones
  • Defense
  • engineering

A new round of tariff chaos involving Donald Trump is sending the overbought markets into a tailspin. The CNN Fear & Greed Index plummeted by a full 32 points last week. After total euphoria, the markets are now back in neutral territory. Some sectors that had performed well, such as defense, AI, and high tech, also had to give up a few percentage points from their recent highs. But it is not all bad news, now investors have the chance to re-enter or top up at more favorable prices. Alternative investments such as Bitcoin and gold corrected slightly, but precious metals quickly rebounded after a brief consolidation. We take a look at some interesting stocks in a challenging market environment and ask: How can investors navigate the summer slump?

Read

Commented by André Will-Laudien on August 1st, 2025 | 07:00 CEST

This could be explosive for e-mobility! Watch out for BYD, Pasinex Resources, VW, and Mercedes

  • Mining
  • zinc
  • Electromobility

The latest quarterly results from the automotive sector have led to further disillusionment. High costs, ever-changing technological requirements, and stricter regulations are leading to declining margins. For two years now, Chinese manufacturers like BYD have been making weekly deliveries by ship to the affluent EU market. Initially highly praised and selling several thousand units quickly, everything now appears to be stalling, as huge stockpiles are suddenly piling up. Investors should keep a close eye on developments. Anyone thinking about modern batteries, for example, cannot ignore the critical metal zinc. Here are a few ideas for your portfolio.

Read

Commented by André Will-Laudien on July 31st, 2025 | 07:25 CEST

Defense remains number one – another 200% with Heidelberger Druck, Almonty, Hensoldt, and DroneShield?

  • Mining
  • Tungsten
  • Defense
  • Drones

When the word "defense" is heard on the trading floor, investors' hearts beat faster. This was recently evident in an 80% rally by Heidelberger Druck in just 48 hours. Who would have thought it, given that Germany has benefited from the "peace dividend" for over 25 years and virtually eliminated its defense capabilities. Today, with conflicts and threats lurking around every corner, weapons and defense technology are back in the spotlight. From an economic perspective, it is encouraging that Germany can reestablish an industrial foothold in this field, especially as the automotive sector is facing headwinds. However, a detached view of the context reveals that profits and prosperity for shareholders are now being generated from the construction of machines that are directed against human life. This is a novelty in the German political potpourri, where the sector has been regulated for years, and the left wing tends to have the say. Where are the opportunities for investors?

Read

Commented by André Will-Laudien on July 31st, 2025 | 07:15 CEST

AI and biotech – A dream team for returns! Evotec and Novo Nordisk in the spotlight, and NetraMark steps on the gas!

  • Biotechnology
  • Biotech
  • AI
  • Pharma

The biotech sector is currently undergoing profound change: big data and artificial intelligence are revolutionizing the way drugs are researched and developed. AI-supported systems help identify molecular target structures more quickly and select active ingredients more precisely. Both start-ups and established companies are increasingly using data-based platforms to shorten development times and make clinical trials more successful. Investors are increasingly directing their capital toward companies that combine biotechnology with modern data analysis. The stock market is ruled by daily madness with figures that are not within the expected range. However, innovative growth markets will remain volatile and attractive at the same time, so bet on the winners!

Read

Commented by André Will-Laudien on July 30th, 2025 | 07:00 CEST

Trump's Tariffs & Takeovers! BioNTech, PanGenomic Health, Pfizer, and Valneva Targeted by Speculators

  • Healthcare
  • healthtech
  • Biotechnology
  • Pharma

The US-EU tariff agreement has now been finalized. Many sectors of the European economy will now face additional burdens and margin cuts. The biotech and pharmaceutical industries have been spared, as medicines and active pharmaceutical ingredients are among the few product groups that are traditionally traded duty-free in transatlantic trade. This is due to international agreements, such as the WTO Pharmaceutical Agreement, which both the EU and the US have signed. Clinical trial drugs, active ingredient imports, and vaccines are also mostly exempt from tariffs. Valneva is currently making headlines with its chikungunya vaccine, BioNTech and Pfizer are continuing to sell COVID-19 vaccines on a small scale, and PanGenomic is surprising everyone with a new AI-powered health platform. A lot is going on in the sector – who are the big earners?

Read

Commented by André Will-Laudien on July 29th, 2025 | 07:05 CEST

Trump tariffs settled? What are the triggers now? Palantir, naoo AG, TeamViewer, and D-Wave

  • Digitization
  • Technology
  • Software
  • computing

With the US-EU agreement on tariffs, markets opened positively yesterday but quickly slipped into negative territory. The reason: the agreement is widely viewed as a "loss-making deal" for the EU. While tariffs of over 20% were averted, 15% still remain. In return, NATO must purchase substantial US military equipment, while US vehicle exports to the EU remain tariff-free. Donald Trump could not have negotiated better himself - a diplomatic failure for Brussels. The decision will have a significant impact on the EU's automotive sector, luxury and consumer goods industries, and technology sector. For example, European wine will cost US consumers about 30% more, factoring in currency losses, which is devastating for European winemakers. All in all, this deal is considered a major setback for free trade, with serious inflationary consequences and declining consumer demand. Investors should reposition themselves, as late summer looks stormy from this perspective alone.

Read